% Expired Patents = 40.0

Forward Citations = 28

Loading Chart...

5 inventors (with patents filed for the assignee):

John Lezdey (4 out of 13 patents)

Darren Lezdey (4 out of 8 patents)

K Anne Kronis (3 out of 6 patents)

4. Jarett Lezdey (1 out of 1 patent)

5. Darren B Lezdey (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 7270979 - DNA for expression of alpha 1-antitrypsin in methylotropic yeast (2007-09-18),

2. 6670325 - Treatment of osteocarcinoma with alpha-1—antitrypsin or secretory leucocyte protease inhibitor (2003-12-30),

3. 6537968 - Treatment of lupus erythematosus (2003-03-25),

4. 6511960 - Cromolyn for eye and ear infections (2003-01-28),

5. 6262020 - Topical wound therapeutic compositions (2001-07-17),

Company Overview

Alphamed Pharmaceuticals Corp. is a leading pharmaceutical company dedicated to developing and marketing innovative healthcare solutions. With a strong focus on research and development, Alphamed Pharmaceuticals Corp. strives to improve the lives of patients by delivering high-quality, affordable medications. Our products cover a wide range of therapeutic areas including cardiovascular health, dermatology, and pain management.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#47 in Clearwater, FL

#1,715 in Florida

#51,620 in US

Clearwater, FL, United States of America

Alphamed Pharmaceuticals Corp.

Forward Citations = 28

5 inventors:

John Lezdey (4 out of 13 patents)

Darren Lezdey (4 out of 8 patents)

K Anne Kronis (3 out of 6 patents)

4. Jarett Lezdey (1 out of 1 patent)

5. Darren B Lezdey (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Alphamed Pharmaceuticals Corp.. Retrieved from https://idiyas.com/company/alphamed-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]